KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Shares Issued (2016 - 2025)

Johnson & Johnson's Shares Issued history spans 17 years, with the latest figure at -$1.8 billion for Q4 2025.

  • For Q4 2025, Shares Issued fell 1576.61% year-over-year to -$1.8 billion; the TTM value through Sep 2025 reached $2.0 billion, up 173.81%, while the annual FY2024 figure was $838.0 million, 80.24% down from the prior year.
  • Shares Issued for Q4 2025 was -$1.8 billion at Johnson & Johnson, down from $1.3 billion in the prior quarter.
  • Across five years, Shares Issued topped out at $4.3 billion in Q3 2023 and bottomed at -$1.8 billion in Q4 2025.
  • The 5-year median for Shares Issued is $215.5 million (2021), against an average of $349.5 million.
  • The largest annual shift saw Shares Issued skyrocketed 1872.73% in 2024 before it crashed 1576.61% in 2025.
  • A 5-year view of Shares Issued shows it stood at $265.0 million in 2021, then increased by 21.13% to $321.0 million in 2022, then skyrocketed by 1224.61% to $4.3 billion in 2023, then tumbled by 97.08% to $124.0 million in 2024, then plummeted by 1576.61% to -$1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Shares Issued are -$1.8 billion (Q4 2025), $1.3 billion (Q3 2025), and $107.0 million (Q2 2025).